Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab

被引：3
|
作者：
Ruck, Jessica M. [1 ]
Broderick, Stephen R. [1 ]
机构：
[1] Johns Hopkins Univ, Dept Surg, Sch Med, Baltimore, MD 21205 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2024年 / 31卷 / 01期
关键词：
D O I：
10.1245/s10434-023-14356-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study
    Zhao, Guangyin
    Zhang, Hongyu
    Xu, Fengkai
    Lu, Chunlai
    Zhu, Qiaoliang
    Grossi, Francesco
    Divisi, Duilio
    Ma, Teng
    Gu, Jie
    Ge, Di
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (01) : 141 - 149
  • [22] Neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for highrisk early-stage TNBC: Overall survival results from the phase III KEYNOTE-522 study
    Schmid, P.
    Cortes, J.
    Dent, R. A.
    McArthur, H. L.
    Pusztai, L.
    Kummel, S.
    Denkert, C.
    Park, Y. H.
    Hui, R.
    Harbeck, N.
    Takahashi, M.
    Im, S-A.
    Untch, M.
    Fasching, P. A.
    Cardoso, F.
    Zhao, J.
    Zhou, X.
    Tryfonidis, K. E.
    Aktan, G.
    O'Shaughnessy, J.
    ANNALS OF ONCOLOGY, 2024, 35 : 1204 - 1205
  • [23] Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy
    Yang, Zhang-Ru
    Liu, Mi-Na
    Yu, Jia-Hua
    Yang, Yun-Hai
    Chen, Tian-Xiang
    Han, Yu-Chen
    Zhu, Lei
    Zhao, Ji-Kai
    Fu, Xiao-Long
    Cai, Xu-Wei
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 2059 - 2073
  • [24] Neoadjuvant nivolumab in early-stage, resectable non-small cell lung cancers.
    Chaft, Jamie E.
    Forde, Patrick M.
    Smith, Kellie Nicole
    Anagnostou, Valsamo
    Cottrell, Tricia
    Taube, Janis M.
    Rekhtman, Natasha
    Merghoub, Taha
    Jones, David Randolph
    Hellmann, Matthew David
    Yang, Stephen C.
    Broderick, Stephen
    Rusch, Valerie W.
    Velculescu, Victor E.
    Topalian, Suzanne Louise
    Pardo, Drew M.
    Brahmer, Julie R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Neoadjuvant chemotherapy in early-stage non-small cell lung cancer
    Salva, Francesc
    Felip, Enriqueta
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 398 - 402
  • [26] Neoadjuvant Pembrolizumab in Early Stage Non-Small Cell Lung Cancer (NSCLC): Toxicity, Efficacy, and Surgical Outcomes
    Ready, N.
    Tong, B.
    Clarke, J.
    Gu, L.
    Wigle, D.
    Dragnev, K.
    Sporn, T.
    Stinchcombe, T.
    D'Amico, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S745 - S745
  • [27] Neoadjuvant versus adjuvant chemotherapy for resectable non-small cell lung cancer debate revisited
    Pu, Chan Yeu
    Yendamuri, Sai
    JOURNAL OF THORACIC DISEASE, 2019, 11 (12) : 5646 - 5648
  • [28] Adjuvant chemotherapy for early-stage non-small cell lung cancer
    Visbal, AL
    Leighl, NB
    Feld, R
    Shepherd, FA
    CHEST, 2005, 128 (04) : 2933 - 2943
  • [29] Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer
    Serke, Monika
    CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 135 - 144
  • [30] Adjuvant chemotherapy in early-stage non-small cell lung cancer
    Dômont, J
    Soria, JC
    Le Chevalier, T
    SEMINARS IN ONCOLOGY, 2005, 32 (03) : 279 - 283
12345